Ever wondered the best example of a character to illustrate the proverbial term of moving from rags to riches, and then wonder no more because Paul Mampilly is that individual. Paul Mampilly started out as a newspaper guy for several years, his initial job being at Palm Beach Letter and later on advanced to run several financial papers as an advisor before finally retiring from active duty at the age of 40 years to concentrate on his family. Before packing and moving back home, he ran a newsletter for the Sovereign Society “an entry level” which was part of the Profits Unlimited service.
The motivating factors for Paul Mampilly was to assist the American people create and amass wealth through growth investing, small cap stocks and special opportunities. He has been an instrumental man in improving the structures of companies as he was at some point part of a team that managed $23million mutual fund and $6 billion hedge fund that Barron named as one of the world’s best hedge funds in 2008. During his tenure, he kept an active and reliable client list that included the European Aristocracy, Swiss private banks and many more.
Paul Mampilly wrote a couple of articles that stood out and some of the articles are: Better than Botox, Our Ebola Stocks could Double Overnight, Don’t miss the biggest Biotech Market ever and How to trade the Ebola Tipping Point just to mention a few.
And yes, you may be still at awe at how Paul’s Stocks were as he was, we can say one of the greatest financial advisors on the face of the earth “immortal” when it comes to tech stocks. This is how his stocks were or still is according to an ad just to give an give an illustration:
“The Greatest Innovation In History…7-Times Bigger Than Computers, Tablets And Smartphones…COMBINED!
“Experts Predict 50 Billion Devices Will Utilize This New Technology By 2020. Early Investors Stand To Reap Tremendous Rewards As Its Growth Surges 8,000%…”
Learn more about Paul Mampilly: https://www.bloomberg.com/research/stocks/private/person.asp?personId=49260032&privcapId=109183793